‹ Back to screener

DIVISLAB.NS Divi's Laboratories Ltd.

Healthcare

Price history

2025-08-21 ₹6028.00
2026-08-21 ₹8522.00
Change over window +41.37%

Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.

Technical indicators

ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.

MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.

Delivery volume

Latest (2026-08-28) 58.6%
Trailing 20-day average 57.4%
Date Traded Qty Delivery Qty Delivery %
2026-08-28 773225 452777 58.56%
2026-08-27 527307 297724 56.46%
2026-08-26 708128 327325 46.22%
2026-08-25 563721 269149 47.75%
2026-08-24 251013 131241 52.28%
2026-08-21 180697 124144 68.70%
2026-08-20 198190 119093 60.09%
2026-08-19 179152 108568 60.60%
2026-08-18 404163 226660 56.08%
2026-08-17 252029 170531 67.66%
2026-08-14 340336 214482 63.02%
2026-08-13 344131 190510 55.36%
2026-08-12 559195 360259 64.42%
2026-08-11 603820 333038 55.16%
2026-08-10 379960 258059 67.92%
2026-08-07 256657 146730 57.17%
2026-08-06 327434 207625 63.41%
2026-08-05 316801 185373 58.51%
2026-08-04 970329 542337 55.89%
2026-08-03 1798150 573969 31.92%

Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers DIVISLAB.NS to fetch more history.

Insider trading activity

Disclosed Person Category Type Mode Quantity Value (₹) Resulting stake
31 Mar 2026 A. Lakshmi Immediate relative Sell Market Sale 500 3206500 0.00% XBRL
29 Dec 2025 P. Rama Sekhar Employees/Designated Employees Sell Gift 500 3211575 0.00% XBRL
29 Dec 2025 Donepudi Sita Immediate relative Buy Gift 500 3211575 0.00% XBRL
11 Dec 2025 SUDHEER KUMAR LINGAMNENI Employees/Designated Employees Sell Gift 1000 6294000 0.00% XBRL
11 Dec 2025 L. Lakshmi Immediate relative Buy Gift 1000 6294000 0.00% XBRL
11 Sep 2025 S. RAMA KRISHNA Employees/Designated Employees Sell Gift 2500 15077500 0.00% XBRL
11 Sep 2025 S Krishna Sree Immediate relative Sell Gift 7500 45232500 0.00% XBRL
02 Jul 2025 K. Sridevi Immediate relative Sell Market Sale 150 1008950 0.00% XBRL
13 Jun 2025 K. Sridevi Immediate relative Sell Market Sale 400 2696744 0.00% XBRL
11 Jun 2025 Yalavarthi Vamsi Krishna Immediate relative Sell Market Sale 200 1335600 0.00% XBRL
28 May 2025 G.Kelitha Immediate relative Sell Market Sale 150 1049000 0.00% XBRL
28 May 2025 Ch. Venu Employees/Designated Employees Sell Market Sale 150 1011750 0.00% XBRL
27 May 2025 DIVI MADHUSUDANA RAO Promoter Group Sell Market Sale 10000 66425100 0.07% XBRL
27 May 2025 K. Sridevi Immediate relative Sell Market Sale 600 4040748 0.00% XBRL
27 May 2025 S Rajani Immediate relative Sell Market Sale 100 674600 0.01% XBRL
26 Mar 2025 Nimmagadda Venkata Anirudh Employees/Designated Employees Sell Market Sale 25000 144528808 0.10% XBRL
15 Mar 2025 G.Kelitha Immediate relative Sell Market Sale 300 1686000 0.00% XBRL
17 Feb 2025 Sridhar Donepudi Employees/Designated Employees Sell Market Sale 500 3070000 0.01% XBRL
28 Dec 2024 Y. Sreedevi Immediate relative Buy Gift 1400 8223600 0.00% XBRL
28 Dec 2024 Y K Chowdary Employees/Designated Employees Sell Gift 1400 8223600 0.00% XBRL

SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers DIVISLAB.NS to fetch more.

Ratios as of FY2025-26 (Annual) · Price ₹8597.00 INR (live) · fetched 2026-08-23 21:45 price stale

Extract this company (financials + ratios + citations): CSV · XLSX

Ratios

P/E
88.72
P/E = Price / EPS
Source trace
P/E = Price / (ProfitOrLossAttributableToOwnersOfParent / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹8,597.00 / (₹25,680,000,000 / 265,000,000 shares) = ₹8,597.00 / ₹96.91 EPS
FY2025-26 · Annual filing
ROE
15.32%
ROE = Net Income / Shareholder Equity
Source trace
ROE = ProfitOrLossAttributableToOwnersOfParent / EquityAttributableToOwnersOfParent → ₹25,680,000,000 / ₹167,610,000,000 = 15.32%
FY2025-26 · Annual filing
Debt/Equity
0.00
Debt/Equity = Total Debt / Shareholder Equity
Source trace
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹0 / ₹167,610,000,000 = 0.00
FY2025-26 · Annual filing
Current Ratio
5.43
Current Ratio = Current Assets / Current Liabilities
Source trace
Current Ratio = CurrentAssets / CurrentLiabilities → ₹110,960,000,000 / ₹20,430,000,000 = 5.43
FY2025-26 · Annual filing
ROCE
20.79%
ROCE = EBIT / (Shareholder Equity + Total Debt)
Source trace
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹34,850,000,000 / (₹167,610,000,000 + ₹0) = 20.79%
FY2025-26 · Annual filing
Dividend Yield
0.35%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price

This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹7,970,000,000 / 265,000,000 shares) / ₹8,597.00 = ₹30.08 / ₹8,597.00
FY2025-26 · Annual filing

Growth & earnings trend

Revenue & Profit CAGR

Revenue (3y, 3.0y actual) 10.8%
Net Profit (3y) 12.1%
Revenue (5y, 3.0y actual) 10.8%
Net Profit (5y) 12.1%
Revenue (10y, 3.0y actual) 10.8%
Net Profit (10y) 12.1%

Operating Margin Trend

Expanding

FY2022-23 30.5%
FY2023-24 27.6%
FY2024-25 31.2%
FY2025-26 33.0%

ROCE Trajectory

FY2022-23 18.6%
FY2023-24 16.0%
FY2024-25 19.5%
FY2025-26 20.8%

Earnings Quality

No persistent gap detected

Net Profit CAGR 12.09% vs CFO CAGR 3.64% over 3.0y (2023-03-31 → 2026-03-31); most recent year: Net Profit +17.21% vs CFO +65.64%

Sector-Relative Percentile (Healthcare)

ROE 54th
ROCE 70th
Debt/Equity 100th
P/E 17th

Quarterly trend

Revenue Net Profit Net Profit (loss quarter)
Metric (to shareholders basis) Q3 FY2023-24 Q4 FY2023-24 Q1 FY2024-25 Q2 FY2024-25 Q3 FY2024-25 Q4 FY2024-25 Q1 FY2025-26 Q2 FY2025-26 Q3 FY2025-26 Q1 FY2026-27 Source
Revenue ₹1,855.00 Cr. ₹2,303.00 Cr. ₹2,118.00 Cr. ₹2,338.00 Cr. ₹2,319.00 Cr. ₹2,585.00 Cr. ₹2,410.00 Cr. ₹2,715.00 Cr. ₹2,604.00 Cr. ₹3,080.00 Cr. RevenueFromOperations
Net Profit ₹358.00 Cr. ₹538.00 Cr. ₹430.00 Cr. ₹510.00 Cr. ₹589.00 Cr. ₹662.00 Cr. ₹545.00 Cr. ₹689.00 Cr. ₹583.00 Cr. ₹902.00 Cr. ProfitOrLossAttributableToOwnersOfParent

Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers DIVISLAB.NS to fetch more.

Source document — income statement (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

ProfitOrLossAttributableToOwnersOfParent25680000000.0
PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital265000000.0
Source document — balance sheet (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

CurrentAssets110960000000.0
CurrentLiabilities20430000000.0
EquityAttributableToOwnersOfParent167610000000.0
BorrowingsCurrent + BorrowingsNoncurrent

My notes